BioNTech :
BNTX
BNTX
Stock Data
$109.00
$2.93 (2.76%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
BioNTech SE is a pioneering biotechnology firm from Mainz, Germany, known for its innovative work in developing immunotherapies for a range of serious diseases, including cancer and infectious diseases. The company is at the forefront of creating treatments such as vaccines and therapies, with several products in various stages of clinical trials targeting conditions like melanoma, prostate cancer, and lung cancer. BioNTech is also notable for its collaborations with major pharmaceutical companies, enhancing its research and development capabilities in the quest to combat challenging diseases.
All BioNTech Articles
40 Articles